Krämer B K, Häussler M, Ress K M, Müller G A, Burger K J, Risler T
Department of Internal Medicine III, University of Tübingen, FRG.
Eur J Clin Pharmacol. 1990;39(4):333-5. doi: 10.1007/BF00315405.
The acute effect of a single oral dose of isradipine 5 mg on blood pressure, renal haemodynamics, electrolyte excretion and plasma renin activity was studied in 10 healthy males. Isradipine did not produce a significant change in systolic or diastolic blood pressure, and glomerular filtration rate, renal plasma flow, renal vascular resistance, and urinary albumin excretion remained constant. There was a marked natriuretic and diuretic effect about 1-3 h after isradipine. Plasma renin activity showed a slight, insignificant increase 1 h after dosing. Uric acid clearance and beta 2-microglobulin excretion showed no significant changes, despite an increase in sodium clearance, suggesting an additional mechanism of action other than the proximal tubular natriuretic effect of isradipine in normotensive volunteers.
在10名健康男性中研究了单次口服5毫克伊拉地平对血压、肾脏血流动力学、电解质排泄和血浆肾素活性的急性影响。伊拉地平对收缩压或舒张压未产生显著变化,肾小球滤过率、肾血浆流量、肾血管阻力和尿白蛋白排泄保持不变。伊拉地平给药后约1-3小时出现明显的利钠和利尿作用。给药1小时后血浆肾素活性有轻微、不显著的升高。尽管钠清除率增加,但尿酸清除率和β2-微球蛋白排泄无显著变化,提示在血压正常的志愿者中,除伊拉地平近端肾小管利钠作用外,还存在其他作用机制。